Theralase Technologies
(OTC) TLTFF
Theralase Technologies Financials at a Glance
Market Cap
$57.30MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
CA$858.25K
Net Income (TTM)
-CA$3.68M
EPS (TTM)
-$0.01
P/E Ratio
-18.63
Dividend
$0.00
Beta (Volatility)
0.74 (Low)
Dividend
$0.00
Beta (Volatility)
0.74 (Low)
Price
$0.20
Volume
15,500
Open
$0.19
Price
$0.20
Volume
15,500
Open
$0.19
Previous Close
$0.20
Daily Range
$0.19 - $0.20
52-Week Range
$0.10 - $0.31
Estimated Earnings Date
Aug 26, 2026
Dividend
$0.00
Beta (Volatility)
0.74 (Low)
Price
$0.20
Volume
15,500
Open
$0.19
Previous Close
$0.20
Daily Range
$0.19 - $0.20
52-Week Range
$0.10 - $0.31
Estimated Earnings Date
Aug 26, 2026
TLTFF News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Theralase Technologies
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
16
CEO
Roger J. Dumoulin-White
Website
www.theralase.comHeadquarters
Toronto, ON M4B 3G4, CA
TLTFF Financials
Key Financial Metrics (TTM)
Gross Margin
51.14%
Operating Margin
-433.40%
Net Income Margin
-429.11%
Return on Equity
-241.53%
Return on Capital
-186.74%
Return on Assets
-94.63%
Earnings Yield
-5.37%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$57.30MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
295.67M
Volume
15.50K
Avg. Volume
191.48K
Financials (TTM)
Gross Profit
CA$498.97K
Operating Income
-CA$3.72M
EBITDA
-CA$3.39M
Operating Cash Flow
-CA$3.18M
Capital Expenditure
CA$14.74K
Free Cash Flow
-CA$3.17M
Cash & ST Invst.
CA$1.01M
Total Debt
CA$432.70K
Theralase Technologies Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
CA$132.98K
+45.8%
Gross Profit
CA$5.13K
-61.4%
Gross Margin
3.86%
N/A
Market Cap
$57.30MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$4.09M
N/A
Employees
14
N/A
Net Income
-CA$1.03M
+29.7%
EBITDA
-CA$973.67K
+30.5%
Quarterly Fundamentals
Total Cash
CA$1.01M
+663.9%
Total Debt
CA$432.70K
+60.5%
Accounts Receivable
CA$855.73K
+27.8%
Inventory
CA$486.77K
-5.5%
Long Term Debt
CA$93.66K
-43.9%
Short Term Debt
CA$338.16K
+229.4%
Return on Assets
-94.63%
N/A
Return on Invested Capital
-1.82%
N/A
Free Cash Flow
-CA$246.07K
+40.3%
Operating Cash Flow
-CA$245.17K
+29.5%